Skip to content

Food Modification to Alter Glycaemia and Insulinaemia

Food Modification to Alter Glycaemia and Insulinaemia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03706378
Enrollment
14
Registered
2018-10-16
Start date
2017-08-18
Completion date
2019-04-04
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The study specifically aims to determine glycemic and insulinemic response of added low GI ingredients, beta-glucan, resistant starch and isomaltulose to foods.

Detailed description

There will be a total of 9 test sessions and each session will last up to 3 hours. At each test session, the following procedures will be performed: two finger-prick blood samples, five minutes apart to measure baseline blood glucose and insulin concentrations. Subject will be served the test food and to consume within15 minutes. Following the test meal, blood samples will be collected at the following time points: 15, 30, 45, 60, 90, 120, 150 and 180min for glucose measurements and insulin measurements will be collected at 30, 60, 90, 120, 150 and 180min.

Interventions

Glucose contains 50g of available carbohydrates

Glucose contains 50g of available carbohydrates

Glucose contains 50g of available carbohydrates

OTHERWheat Yellow Noodle

Wheat Yellow Noodle will contain 50g of available carbohydrate

OTHERBeta-glucan yellow Noodle

Beta-glucan yellow noodle will contain 50g of available carbohydrate

OTHERRice Roll

Rice Roll will contain 50g of available carbohydrate

OTHERRice Roll with resistant starch

Rice Roll fortified with resistant starch will contain 50g of available carbohydrate

OTHERSucrose Jelly

Jelly and bread will contain 50g of available carbohydrate. The jelly will contain 25g of sucrose

OTHERIsomaltulose Jelly

Jelly and bread will contain 50g of available carbohydrate. The jelly will contain 25g of Isomaltulose

Sponsors

Health Promotion Board, Singapore
CollaboratorOTHER_GOV
Singapore Institute of Food and Biotechnology Innovation
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
21 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Males * Chinese ethnicity * Age ≥21 and ≤ 40 years * Body mass index between 18.5 to 25 kg/m2 * Normal blood pressure ≤140/90 mmHg * Fasting blood glucose \<6.0 mmol/L * In general good health

Exclusion criteria

* Current smoker * Have metabolic diseases (such as diabetes, hypertension etc) * Have glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) * Have medical conditions and/or taking medications known to affect glycaemia (glucocorticoids, thyroid hormones, thiazide diuretics) * Have an ongoing infection or currently undergoing treatment at the time of screening * Have known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV) * Have active Tuberculosis (TB) or currently receiving treatment for TB * Intolerances or allergies to any foods * Partake in sports at the competitive and/or endurance levels * Intentionally restrict food intake

Design outcomes

Primary

MeasureTime frameDescription
Glucoseup to 180 minutesBlood glucose will be collected using finger prick method and analysed using Hemocue analyser
Insulinup to 180 minutesBlood glucose will be collected using finger prick method and analysed using Cobas analyser

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026